Cargando…

Natriuretic peptide pathways in heart failure: further therapeutic possibilities

The discovery of the heart as an endocrine organ resulted in a remarkable recognition of the natriuretic peptide system (NPS). Specifically, research has established the production of atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) from the heart, which exert pleiotropic cardio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sangaralingham, S Jeson, Kuhn, Michaela, Cannone, Valentina, Chen, Horng H, Burnett, John C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Spotlight Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897690/ https://www.ncbi.nlm.nih.gov/pubmed/36004816 http://dx.doi.org/10.1093/cvr/cvac125

Ejemplares similares

C-type natriuretic peptide: the heart’s guardian angel
por: Sangaralingham, S Jeson, et al.
Publicado: (2020)

M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics
por: McKie, Paul M, et al.
Publicado: (2013)

M‐Atrial Natriuretic Peptide and Nitroglycerin in a Canine Model of Experimental Acute Hypertensive Heart Failure: Differential Actions of 2 cGMP Activating Therapeutics
por: McKie, Paul M., et al.
Publicado: (2014)

EVIDENCE FOR ANGIOTENSIN II AS A NATURALLY EXISTING SUPPRESSOR FOR THE NATRIURETIC PEPTIDE SYSTEM
por: Ma, Xiao, et al.
Publicado: (2023)

A novel designer natriuretic peptide CD-NP suppresses TGF-beta 1 induced collagen Type I production in human cardiac fibroblasts
por: Ichiki, Tomoko, et al.
Publicado: (2009)

Atrial Natriuretic Peptide: A Molecular Target of Novel Therapeutic Approaches to Cardio-Metabolic Disease
por: Cannone, Valentina, et al.
Publicado: (2019)

Chronic natriuretic peptide protein therapeutics
por: Chen, Horng H, et al.
Publicado: (2013)

Designer natriuretic peptides for heart failure: advanced in clinical development
por: Burnett, John
Publicado: (2011)

Modulating cGMP in heart failure by novel natriuretic peptides
por: Burnett, John C
Publicado: (2009)

Natriuretic Peptides and Blood Pressure Homeostasis: Implications for MANP, a Novel Guanylyl Cyclase a Receptor Activator for Hypertension
por: Cannone, Valentina, et al.
Publicado: (2022)

Early activation of deleterious molecular pathways in the kidney in experimental heart failure with atrial remodeling
por: Ichiki, Tomoko, et al.
Publicado: (2017)

Using machine learning to uncover heterogeneity of beta blocker response in heart failure
por: Tison, Geoffrey H.
Publicado: (2022)

A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure
por: Kawakami, Rika, et al.
Publicado: (2018)

A biodegradable in-situ polymer precipitation delivery system for sustained delivery of a novel chimeric natriuretic peptide CD-NP in an experimental model of myocardial infarction
por: Lim, Soo Ghim, et al.
Publicado: (2013)

C-Type natriuretic peptide: a potential urinary biomarker for renal remodeling and fibrosis during aging
por: Sangaralingham, Jeson S, et al.
Publicado: (2011)

Innovative Therapeutics: Designer Natriuretic Peptides
por: Meems, Laura M.G., et al.
Publicado: (2016)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions
por: Pugliese, Nicola Riccardo, et al.
Publicado: (2022)

Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolism
por: Glöde, Anja, et al.
Publicado: (2017)

SARS-CoV-2 vaccination site as possible pitfall on somatostatin receptor imaging
por: Kolade, Olumayowa U., et al.
Publicado: (2022)

Race, ancestry, and genetic risk for kidney failure
por: Nicholas, Susanne B., et al.
Publicado: (2022)

A case of retractable helix lead auto‐retraction: A possible cause of deep septal lead dislodgement
por: Suzuki, Keisuke, et al.
Publicado: (2023)

Brain Natriuretic Peptide Biomarkers in Current Clinical and Therapeutic Scenarios of Heart Failure
por: Alcidi, Gianmarco, et al.
Publicado: (2022)

Harnessing the therapeutic vulnerability of MMR heterogeneity in colorectal cancer
por: Anandappa, Gayathri, et al.
Publicado: (2023)

HeartLogic multisensor algorithm response prior to ventricular arrhythmia events
por: Kataoka, Shohei, et al.
Publicado: (2023)

A racing heart post‐Pfizer/BioNTech BNT162b2
por: Teo, Hooi Khee, et al.
Publicado: (2022)

Usefulness of “heart‐shaped sign” during “spaghetti twisting” technique in transvenous lead extraction
por: Okada, Takuya, et al.
Publicado: (2023)

Cholinergic anti-inflammatory pathway and COVID-19
por: Mehranfard, Danial, et al.
Publicado: (2022)

Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies
por: de Wit, Sanne, et al.
Publicado: (2022)

Decrypting the potency of anti-cancer therapeutics by using mass spectrometry to quantify post-translational modifications
por: Herbst, Sophie A., et al.
Publicado: (2023)

A manifest nodoventricular accessory pathway with unusual electrophysiological manifestations
por: Li, Jun, et al.
Publicado: (2022)

The other side of the coin: dissecting molecular mechanisms behind hereditary breast cancer in search of therapeutic opportunities
por: Stella, Stefania, et al.
Publicado: (2021)

N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE AND IN-HOSPITAL MORTALITY IN HOSPITALIZED COVID-19 PATIENTS: EXPERIENCE FROM A LARGE HEALTHCARE NETWORK SYSTEM
por: Moges, Fekadesilassie, et al.
Publicado: (2021)

The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics
por: Woodruff, Trent M., et al.
Publicado: (2020)

Long noncoding RNA amplified in lung cancer rewires cancer pathways
por: Martínez-Terroba, Elena, et al.
Publicado: (2020)

Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker
por: Tan, Nicholas Y., et al.
Publicado: (2021)

Mitochondrial membrane biogenesis: A new pathway for lipid transport mediated by PERK/E-Syt1 complex
por: Leterme, Sébastien, et al.
Publicado: (2023)

Termination of slow‐fast atrioventricular reentrant tachycardia by a single cryoablation of the slow pathway guided by a fractionation map
por: Wakamatsu, Yuji, et al.
Publicado: (2023)

Clinical Significance of B-type Natriuretic Peptide in Heart Failure
por: Yoo, Byung-Su
Publicado: (2014)

The Effects of Exercise on Natriuretic Peptides in Individuals without Heart Failure
por: Hamasaki, Hidetaka
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0oo864gdck956o1pd012tdjvar